Moderna to seek emergency use of COVID-19 vaccine if data shows efficacy
Moderna's vaccine candidate - mRNA-1273 - is nearing the finish line in its push to enroll 30,000 individuals in a late-stage trial of a novel coronavirus vaccine.
A volunteer receives an injection in a human clinical trial for a potential vaccine against the novel coronavirus, at the Baragwanath hospital in Soweto, South Africa, June 24, 2020(photo credit: REUTERS/SIPHIWE SIBEKO)ByREUTERS